Treatment of Diabetes Learning Objectives By the end of this session you should be able to: Define the goals of therapy for type 1 and 2 diabetes in accordance with the American Diabetes Association Clinical Practice Guidelines 2020 & 2021, including the recently updated indications for: Metformin GLP-1 receptor agonists SGLT-2 inhibitors List the categories of pharmacologic agents used in the management of patients with type 1 and 2 diabetes Explain the following for each drug category: mechanisms of action indications contraindications potential side effects major advantages /disadvantages Identify the drug category that individual diabetic medications belong to based upon their non-proprietary names (e.g
One of the most compelling aspects of this peptide combination is its versatility
(2015) performed an OL pilot study with a total sample of 41 children receiving omega-3 fatty acids
and more If you spend any time on social media, youve probably heard of GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Also, they're not contagious, so you don't have to worry about spreading it to others or catching it from someone
Serial blood samples were collected for PK analysis at pre-specified intervals up to 672 h after the final dose (pre-dose, 4, 6, 12, 24, 36, 48, 72, 120, 168, 336, and end-of-study at 672 h)